BPA Call N4034512A0022-0003

This firm fixed price delivery order from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awards The Mitchell Group, Inc. doing business as Mitchell Group Inc. to conduct a COVID-19 seroprevalence study in the population of Mali from June 16, 2021 through June 15, 2022. The Mitchell Group will perform this work under contract number HHSN272201700050I task order number 34 as part of the National Institutes of Health's...

This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Emory University's Office of Sponsored Programs Division. The contract, valued at $116,930.00, is for the "MALARIA MULTIPLICITY MOI" requirement and is a firm fixed-price purchase order with a completion date of April 30, 2021. The work will be performed in Atlanta, Georgia. No set-aside designation was used for this award. Emory University is a private research...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $89,054.88 firm fixed price purchase order to Sanaria Inc. to provide asexual malaria blood culture service. The contract calls for monthly delivery of Plasmodium falciparum asexual parasites at over 90% ring stage, complete culture medium, and human blood for use in the National Center for Translational Sciences' malaria viability assays to support...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $148,979.00 firm-fixed-price definitive contract to the London School of Hygiene and Tropical Medicine, a non-profit educational institution, for a project titled "FOR OTHER FUNCTIONS CONCORD-3 STUDY: LONG-TERM SURVEILLANCE OF CANCER SURVIVAL WORLD-WIDE." The contract, which does not have a set-aside designation, was awarded on September 25, 2017, with a completion date of September 24,...

This definitive cost-no-fee contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to The Johns Hopkins University to operate a facility for testing malaria vaccines in adult human subjects. The $14,621,520.76 contract, which does not have a set-aside designation, commenced on September 30, 2004 and is scheduled for completion on December 2, 2014. The Johns Hopkins University, a private non-profit research university, has a long history of supporting federal...

This is a $3,397,349.60 fixed-price level of effort contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Sanaria Inc., a veteran-owned biotechnology company, for a Phase III clinical trial of an investigational malaria vaccine. The contract is for the production and delivery of Plasmodium falciparum sporozoites, the parasite that causes malaria, to support the clinical trial. Sanaria Inc. has previously provided services to the National Institutes of Health and...

The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government, awarded a $13,505.01 firm fixed-price purchase order contract to University Research Co., LLC to provide support services to conduct studies on malaria in Cambodia. The contract, which has no set-aside designation, is titled "AMBIS #1776938 SUPPORT SERVICES TO CONDUCT STUDIES ON MALARIA IN CAMBODIA (COW BAITED TENT STUDY)" and has an ultimate completion date of September 15,...

This $153,000 firm fixed price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to the University of California Los Angeles, doing business as UCLA, to provide research assistance services in support of planned VA medical studies investigating drug resistance in Plasmodium parasites. Specifically, UCLA will cultivate three Plasmodium falciparum parasite strains and apply drug pressure with T16.5, an acridone...

The U.S. Department of Health and Human Services, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract in the amount of $299,974 to Crosslife Technologies Inc., a self-certified small disadvantaged business, for a Small Business Innovation Research (SBIR) Phase I project titled "A Rapid Nucleic Acid Test for the Point of Care Detection of Malaria." The contract was set aside for total small...

The U.S. Navy's Bureau of Medicine and Surgery awarded a $87,000.00 firm-fixed-price purchase order to the National Malaria Control Program, a foreign government entity, for vector surveillance services in Yemen. The contract, awarded on August 1, 2022, has an ultimate completion date of July 31, 2024. This award was made without a set-aside designation, and the original solicitation was not a request for competitive proposals. The National Malaria Control Program specializes in vector...